1. Lu, Xiaoya, Zhuang, Haifeng, Yu, Qingfeng, Shen, Jianping, Xu, Rongzhen. 2018. Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia. In Experimental cell research, 371, 409-416. doi:10.1016/j.yexcr.2018.08.035. https://pubmed.ncbi.nlm.nih.gov/30179602/
2. Ou, Yuhong, Luo, Hongtao, Zhang, Qiuning, Yang, Zhen, Wang, Xiaohu. . UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma. In Frontiers in bioscience (Landmark edition), 29, 144. doi:10.31083/j.fbl2904144. https://pubmed.ncbi.nlm.nih.gov/38682183/
3. Chen, Hailong, Li, Huifang, He, Minke, Shi, Ming, Kan, Anna. 2024. UBA2 SUMOylates NQO1 and promotes the proliferation of hepatocellular carcinoma by modulating the MAPK pathway. In Cancer science, 115, 2998-3012. doi:10.1111/cas.16290. https://pubmed.ncbi.nlm.nih.gov/39013843/
4. Jiang, Biying, Fan, Xiaoxi, Zhang, Di, Liu, Haifeng, Fan, Chuifeng. 2019. Identifying UBA2 as a proliferation and cell cycle regulator in lung cancer A549 cells. In Journal of cellular biochemistry, 120, 12752-12761. doi:10.1002/jcb.28543. https://pubmed.ncbi.nlm.nih.gov/30848500/
5. He, Ping, Sun, Xun, Cheng, Hong-Jing, Hao, Yue-Ming, Meng, Xiang-Wei. 2018. UBA2 promotes proliferation of colorectal cancer. In Molecular medicine reports, 18, 5552-5562. doi:10.3892/mmr.2018.9613. https://pubmed.ncbi.nlm.nih.gov/30387828/
6. Du, Xinbo, Shi, Jianguo. 2021. UBA2 promotes the progression of renal cell carcinoma by suppressing the p53 signaling. In Irish journal of medical science, 191, 1555-1560. doi:10.1007/s11845-021-02763-4. https://pubmed.ncbi.nlm.nih.gov/34467471/
7. Zhang, Juan, Ouyang, Fan, Gao, Anbo, Long, Yunzhu, Li, Yukun. 2024. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. In Molecular cancer, 23, 94. doi:10.1186/s12943-024-02009-8. https://pubmed.ncbi.nlm.nih.gov/38720298/